1. Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke JAMA. 2004;291(5):576-584. doi:10.1001/jama.291.5.576 IRB indicates institutional review board. Figure Legend:

2. Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke JAMA. 2004;291(5):576-584. doi:10.1001/jama.291.5.576 For the warfarin group: log-rank z score,0.68; P =.93; relative hazard ratio, 0.99; 95% confidenceinterval (CI), 0.76-1.28. For the aspirin group: log-rank z score, −1.28; P =.85; relative hazardratio, 1.03; 95% CI, 0.77-1.37. APASS indicates Antiphospholipid Antibodiesand Stroke Study; aPL, antiphospholipid antibody. Figure Legend:

3. Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke JAMA. 2004;291(5):576-584. doi:10.1001/jama.291.5.576 For lupus anticoagulant antibody (LA)+/anticardiolipin antibody (aCL)+:log-rank z score, 10.22; P =.07; relative hazard ratio, 1.36; 95% confidence interval (CI), 0.97-1.92.For LA+/aCL−: log-rank z score, −11.84; P =.15; relative hazard ratio, 0.79; 95% CI, 0.58- 1.08.For LA−/aCL+: log-rank z score, 2.46; P =.77; relative hazard ratio, 1.04; 95% CI, 0.81-1.32.For LA−/aCL−: log-rank z score, −0.83.APASS indicates Antiphospholipid Antibodies and Stroke Study. Figure Legend: